Skip to main content

Estrogen Replacement Therapy

  • Chapter
The Menopause

Part of the book series: Clinical Perspectives in Obstetrics and Gynecology ((CPOG))

Abstract

Estrogen replacement therapy has been scrutinized closely and the biologic effects of various estrogens have been examined extensively during the past 5 years.1–14 During the early 1960s, estrogens were used liberally in an attempt to perpetuate youth for menopausal women. It was common practice at that time to prescribe estrogens routinely to nearly every postmenopausal woman on the premise that estrogens protected women against the ravages of aging. This “feminine forever” concept was challenged in the mid-1970s when several investigators noted an increased incidence of endometrial cancer in the United States.15,16 They suggested that the prolonged exposure of women with uteri to unopposed estrogen was responsible for these findings. These suggestions provoked widespread concern among laypersons and physicians about the potential risks of estrogen replacement therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Shoemaker ES, Forney JP, MacDonald PC. Estrogen treatment of postmenopausal women: benefits and risks. JAMA. 1977; 238:1524–1530.

    Google Scholar 

  2. Greenblatt RB, Causa H, Studd J (eds). The menopause. Clin Obstet Gynecol. 1977; 4(1): 1–258.

    Google Scholar 

  3. Hulka BS. Effect of exogenous estrogen on postmenopausal women: the epidemiologic evidence. Obstet Gynecol Survey 1980; 35:389–399.

    Article  Google Scholar 

  4. Schiff I, Ryan KJ. Benefits of estrogen replacement. Obstet Gynecol Survey 1980; 35:400–411.

    Article  Google Scholar 

  5. Geola FL, Frumar AM, Tataryn IV, et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab. 1980; 51:620–625.

    Article  PubMed  CAS  Google Scholar 

  6. Worley FJ (ed). The menopause. Clin Obstet Gynecol. 1981; 24(1): 163–324.

    Google Scholar 

  7. Mosher BA, Whelan EM. Postmenopausal estrogen therapy: a review. Obstet Gynecol Survey 1981; 36:467–475.

    Article  CAS  Google Scholar 

  8. Judd HL, Cleary RE, Creasman WT, et al. Estrogen replacement therapy. Obstet Gynecol. 1981; 58:267–275.

    PubMed  CAS  Google Scholar 

  9. Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Steril. 1982; 37:5–25.

    PubMed  CAS  Google Scholar 

  10. Gambrell RD. The menopause; benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril. 1982; 37:457–473.

    PubMed  Google Scholar 

  11. Mandel FP, Geola FL, Lu JK, et al. Biologic effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol. 1982; 59:673–679.

    PubMed  CAS  Google Scholar 

  12. Upton GV. The perimenopause: physiologic correlates and clinical management. J Reprod Med. 1982; 27:1–28.

    PubMed  CAS  Google Scholar 

  13. Carr BR, MacDonald PC (1983) Estrogen treatment of postmenopausal women. In: Siperstein MD, Advances in internal medicine, 28:491. Chicago: Year Book Medical.

    Google Scholar 

  14. Elkik F, Gompel A, Mercier-Bodard C, et al. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol. 1982; 143:888–892.

    PubMed  CAS  Google Scholar 

  15. Smith DC, Prentice R, Thompson DJ, Henmann WL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164–1167, 1975.

    Article  PubMed  CAS  Google Scholar 

  16. Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial carcinoma in a retirement community. N Engl J Med 294:1262–1267, 1976.

    Article  PubMed  CAS  Google Scholar 

  17. Mandel FP, Davidson BJ, Erlik Y, et al. Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med. 1982; 27:511–514.

    PubMed  CAS  Google Scholar 

  18. Schiff I. The effects of progestins on vasomotor flushes. J Reprod Med. 1982; 27:498–502.

    PubMed  CAS  Google Scholar 

  19. Riggs BL, Seeman E, Hodgson SF, et al. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med. 1982; 306:446–450.

    Article  PubMed  CAS  Google Scholar 

  20. Ross RK, Paganini-Hill A, Gerkins VR, et al. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980; 243:1635–1639.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Edman, C.D. (1983). Estrogen Replacement Therapy. In: Buchsbaum, H.J. (eds) The Menopause. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5525-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5525-3_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-5527-7

  • Online ISBN: 978-1-4612-5525-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics